NEWS
New MGA Analysis of Biosimilar Coverage in Commercial Medical Benefit
A new MGA white paper from CEO Alex Brill and Principal Christy Robinson shows a positive outlook for biosimilar coverage in the commercial medical benefit.
Narrow House GOP Victory Should Point Toward Policy Development Agenda
Two years ago, in the aftermath of the 2020 Congressional election, I wrote: Democrats will retain the majority and the Speaker of the House—second in line to the presidency—will again be Nancy Pelosi.
Don’t Let Pandemic Fatigue Inhibit Pandemic Preparedness
Almost three years after COVID-19 changed the world, pandemic fatigue is in full swing.
American Renewal: A Simpler, More Responsible, and Pro-Growth Tax System
In 2017, lawmakers passed the Tax Cuts and Jobs Act (TCJA), the most significant overhaul of US tax law since 1986.
Macroeconomics of the Child Tax Credit
The nonpartisan Joint Committee on Taxation (JCT) recently provided lawmakers with a dynamic score and macroeconomic analysis of a policy to permanently extend the child tax credit (CTC) enacted in President Joe Biden’s American Rescue Plan Act of 2021 (ARP).
2022 Midterms: How a Democratic or GOP Congress May Impact Your Federal Taxes
“If Republicans take control of Congress in this fall’s election, protecting previously passed policies will be among the party’s top priority, said Alex Brill, a senior fellow at the American Enterprise Institute for Public Policy Research, a conservative think tank based in Washington, D.C. “
‘The Price of Business’: Discussing State Taxation of Student Loan Forgiveness
On October 12, Alex Brill joined Kevin Price on ‘The Price of Business’ to discuss the state tax implications of President Biden’s student loan relief plan.
More Concerns with the Massachusetts Millionaire’s Tax
Yesterday, the Wall Street Journal editorial board rightly noted multiple concerns with a November ballot initiative in Massachusetts that would amend the state constitution and establish a millionaire’s tax.
Revisiting the Tax Treatment of Pass-Through Businesses: A Panel Discussion
On October 3, AEI’s Alex Brill and Kyle Pomerleau hosted a panel of experts to discuss the tax treatment of pass-through businesses and opportunities for reform.
President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes
In a previous post, we explained how President Joe Biden’s student loan forgiveness plan could result in $4.8 billion in additional state income taxes from borrowers in seven states.
President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues
More than 43 million Americans will see their student loan debt partially or completely forgiven under President Biden’s student loan relief plan
Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition
Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to discuss his latest report for CAPD.
New PCMA Podcast Highlights Importance of Prescription Drug Rebates
“The rebate rule came out of a concern about rising drug prices,” said Brill. “But it is a policy that is chock full of unintended consequences. If it were implemented, we’d have fewer discounts. That’s definitely not going to lower overall spending in the healthcare sector.”
Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology
MGA releases an updated report, “Biosimilar Market Opportunities in Ophthalmology.”
Health Care Jobs Gap Remains Serious
Employment in the health care sector increased by 56,700 in June, more than double the average monthly pace in this sector during the last year, according to last Friday’s jobs report.
- Implications of Cannabis Legalization for the US Federal Budget
- Biden Budget Proposes a Step Toward Biologic Drug Competition
- MGA Releases Economic Impact Report for Multinational Pharmaceutical Company
- MGA’s Alex Brill on CNBC’s Squawk Box Discussing Tackling the Tax Gap
- The Next Tax Fight: SALT
- Alex Brill on Single-Payer Health Care System and Drug Costs
- New MGA Analysis Finds Drug Rebates Not Associated with List Price Increases
- The Threat to Preferred Pharmacy Networks
- Alex Brill mentioned on MSN
- Alex Brill Speaks on Consequences of Proposed PBM Constraints
